Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial.
| Autor: | Wijesinghe, Harindu1, Galappatthy, Priyadharshini2,3 p.galappatthy@pharm.cmb.ac.lk, de Silva, Rajiva4, Seneviratne, Suranjith L.5,6, Saravanamuttu, Ushagowry1, Udagama, Preethi7, Hart, Melanie8, Kelleher, Peter8, Senerath, Upul9, Fernandopulle, Rohini10, Weerasekera, Lilani P.1, Wijayaratne, Lalith S.1 |
|---|---|
| Zdroj: | BMC Musculoskeletal Disorders. 7/19/2017, Vol. 18, p1-10. 10p. 1 Diagram, 2 Charts, 2 Graphs. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|